Cargando…

PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Truong, Thu H., Benner, Elizabeth A., Hagen, Kyla M., Temiz, Nuri A., Kerkvliet, Carlos Perez, Wang, Ying, Cortes-Sanchez, Emilio, Yang, Chieh-Hsiang, Trousdell, Marygrace C., Pengo, Thomas, Guillen, Katrin P., Welm, Bryan E., Dos Santos, Camila O., Telang, Sucheta, Lange, Carol A., Ostrander, Julie H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238912/ https://www.ncbi.nlm.nih.gov/pubmed/34103681 http://dx.doi.org/10.1038/s41388-021-01871-w

Ejemplares similares

OR16-2 Steroid Receptor Co-Activator Complexes Regulate Metabolic PFKFB Enzymes to Drive Therapy Resistant ER+ Breast Cancer
por: Benner, Elizabeth, et al.
Publicado: (2022)

Steroid Receptor Co-Activators Regulate Metabolic Kinases to Drive Therapy Resistant ER+ Breast Cancer
por: Truong, Thu Ha, et al.
Publicado: (2021)

Simultaneous inhibition of the estrogen receptor and 6-phosphofructo-2-kinase (PFKFB3) for the treatment of ER+ breast cancer
por: Imbert-Fernandez, Yoannis, et al.
Publicado: (2014)

PELP1 Suppression Inhibits Colorectal Cancer through c-Src Downregulation
por: Ning, Zhifeng, et al.
Publicado: (2014)

Expression of estrogen receptors, PELP1, and SRC in human spermatozoa and their associations with semen quality
por: Skibińska, Izabela, et al.
Publicado: (2022)

Targeting the sugar metabolism of tumors with a first-in-class 6-phosphofructo-2-kinase (PFKFB4) inhibitor
por: Chesney, Jason, et al.
Publicado: (2015)

OR05-04 Steroid Receptor Co-Activators Complexes Cooperate with Progesterone Receptors (PR) to Reprogram Metabolic Pathways that Drive Therapy Resistant Populations in ER+ Breast Cancer
por: Truong, Thu H, et al.
Publicado: (2020)

Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
por: Telang, Sucheta, et al.
Publicado: (2014)

Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
por: Klarer, Alden C, et al.
Publicado: (2014)

PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway
por: Yan, Hongzhu, et al.
Publicado: (2020)

Altered Expression of ESR1, ESR2, PELP1 and c-SRC Genes Is Associated with Ovarian Cancer Manifestation
por: Englert-Golon, Monika, et al.
Publicado: (2021)

Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer
por: Flågeng, Marianne Hauglid, et al.
Publicado: (2015)

Cytoplasmic PELP1 and ERRgamma Protect Human Mammary Epithelial Cells from Tam-Induced Cell Death
por: Girard, Brian J., et al.
Publicado: (2015)

Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer
por: Dasgupta, Subhamoy, et al.
Publicado: (2018)

Fructose-2,6-Bisphosphate synthesis by 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth
por: Chesney, Jason, et al.
Publicado: (2014)

OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins
por: Ostrander, Julie, et al.
Publicado: (2019)

Characterization of Organoid Cultures to Study the Effects of Pregnancy Hormones on the Epigenome and Transcriptional Output of Mammary Epithelial Cells
por: Ciccone, Michael F., et al.
Publicado: (2020)

The kinase domain of PFKFB4 is required to stimulate the glucose metabolism and growth of H460 xenografts
por: Clark, J, et al.
Publicado: (2014)

PFKFB4 promotes lung adenocarcinoma progression via phosphorylating and activating transcriptional coactivator SRC-2
por: Meng, Jiguang, et al.
Publicado: (2021)

Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes
por: Daniel, Andrea R., et al.
Publicado: (2014)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
por: Mondal, Susmita, et al.
Publicado: (2018)

PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
por: Rees, Michael, et al.
Publicado: (2020)

Expression of ERα, ERβ and Co-Regulator PELP1/MNAR in Colorectal Cancer: Prognostic Significance and Clinicopathologic Correlations
por: Grivas, Petros D., et al.
Publicado: (2009)

Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR
por: Vadlamudi, Ratna K., et al.
Publicado: (2007)

PELP: Accounting for Missing Data in Neural Time Series by Periodic Estimation of Lost Packets
por: Dastin-van Rijn, Evan M., et al.
Publicado: (2022)

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
por: Altwegg, Kristin A., et al.
Publicado: (2023)

Increased expression of PELP1 in human sperm is correlated with decreased semen quality
por: Skibinska, Izabela, et al.
Publicado: (2018)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

Targeting PELP1 Attenuates Angiogenesis and Enhances Chemotherapy Efficiency in Colorectal Cancer
por: Zhu, Jianlin, et al.
Publicado: (2022)

Cryo-EM reveals the architecture of the PELP1-WDR18 molecular scaffold
por: Gordon, Jacob, et al.
Publicado: (2022)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

Roles of PFKFB3 in cancer
por: Shi, Linlin, et al.
Publicado: (2017)

Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions
por: Okabe, Seiichi, et al.
Publicado: (2022)

Lactoferrin: A Critical Player in Neonatal Host Defense
por: Telang, Sucheta
Publicado: (2018)

The Clinical Value of PELP1 for Breast Cancer: A Comparison with Multiple Cancers and Analysis in Breast Cancer Subtypes
por: Wang, Xingen, et al.
Publicado: (2019)

Targeting steroid receptor co-activators to inhibit breast cancer stem cells
por: Truong, Thu H., et al.
Publicado: (2018)

SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway
por: Zhao, Shu-Jie, et al.
Publicado: (2018)

The influence of PFK-II overexpression on neuroblastoma patients’ survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4
por: Trojan, Sonia E., et al.
Publicado: (2019)

6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
por: Yalcin, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n8sn7dt6ugt7fej2risecjd8vm